1. Home
  2. SDGR vs BLX Comparison

SDGR vs BLX Comparison

Compare SDGR & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • BLX
  • Stock Information
  • Founded
  • SDGR 1990
  • BLX 1977
  • Country
  • SDGR United States
  • BLX Panama
  • Employees
  • SDGR N/A
  • BLX N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • BLX Commercial Banks
  • Sector
  • SDGR Health Care
  • BLX Finance
  • Exchange
  • SDGR Nasdaq
  • BLX Nasdaq
  • Market Cap
  • SDGR 1.8B
  • BLX 1.3B
  • IPO Year
  • SDGR 2020
  • BLX N/A
  • Fundamental
  • Price
  • SDGR $21.93
  • BLX $37.68
  • Analyst Decision
  • SDGR Buy
  • BLX
  • Analyst Count
  • SDGR 7
  • BLX 0
  • Target Price
  • SDGR $32.29
  • BLX N/A
  • AVG Volume (30 Days)
  • SDGR 1.1M
  • BLX 132.6K
  • Earning Date
  • SDGR 04-30-2025
  • BLX 04-17-2025
  • Dividend Yield
  • SDGR N/A
  • BLX 6.61%
  • EPS Growth
  • SDGR N/A
  • BLX 23.03
  • EPS
  • SDGR N/A
  • BLX 5.60
  • Revenue
  • SDGR $207,539,000.00
  • BLX $286,337,000.00
  • Revenue This Year
  • SDGR $28.69
  • BLX $15.34
  • Revenue Next Year
  • SDGR $14.95
  • BLX $6.42
  • P/E Ratio
  • SDGR N/A
  • BLX $6.83
  • Revenue Growth
  • SDGR N/A
  • BLX 19.98
  • 52 Week Low
  • SDGR $16.67
  • BLX $27.37
  • 52 Week High
  • SDGR $29.15
  • BLX $42.88
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 47.81
  • BLX 44.51
  • Support Level
  • SDGR $19.48
  • BLX $37.68
  • Resistance Level
  • SDGR $21.90
  • BLX $42.88
  • Average True Range (ATR)
  • SDGR 1.65
  • BLX 1.28
  • MACD
  • SDGR -0.04
  • BLX -0.30
  • Stochastic Oscillator
  • SDGR 51.20
  • BLX 4.41

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration across the region. The Bank provides foreign trade solutions to a select client base of premier Latin-American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments the Commercial Business Segment and the Treasury Business Segment.

Share on Social Networks: